Equels Thomas K.

Hemispherx Biopharma, Inc.

CEO & President, Director

Avg. Two Year Performance

(54%) Avg. Purchase Return (24%) Compound

No Sale Track Record

Holdings: 716.46K shares

Last Three Months: 05-Feb-24 -- 04-May-24

0 Net Amount

Buy:	0	--
Sell:	0	--

Sentiment

Insider Trading Sentiment: Accumulate

Company Sentiment

Biotechnology

Drugs

Two Year Chart

05-May-22 -- 04-May-24

Price ($)

Two Year Stock Price Chart

Sentiment

Company Sentiment

Most Recent Insider Transactions